Cite

HARVARD Citation

    Huang, Y. et al. (2018). Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials. Human vaccines & immunotherapeutics. 14 (9), pp. 2116-2127. [Online]. 
  
Back to record